Dear %%First Name|reader%%, Something big is happening. A small group of stocks have started moving, and this is just the start.  A $3 trillion tech disruption tidal wave could send these stocks soaring, and here’s how you can get in.   The early leaders are already with this. Take Teledoc (TDOC) for example. It’s a…

Down More Than 99% – BUY Buy low, sell high.   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  Dear %%First Name|reader%%, Buy low, sell high.  Your investment journey starts with buying low – and we’ve made it easy for you to do that right now. We’ve curated two stocks for you that can’t drop much lower.  Both of…

Dear %%First Name|reader%%, When the world’s greatest value investor can’t find any value, you should take note. It is not easy to be an investor today. Stocks are historically expensive. The Shiller Price-To-Earnings Ratio is higher than it was in 1929 and 2008. You know how that turned out.  Even Warren Buffett, the…

ATAI Life Science’s IPO in 2021 is expected to be another big industry catalyst. But one company that might NOT benefit is Compass Pathways.

Numinus announces a bought deal financing at CAD$0.68 cents.

Cybin Corp acquires Adelia Therapeutics in an all-stock transaction valued at CAD$20.2 million.

One of Bitcoin’s most prominent investors is making a new monster bet.

The federal marijuana legalization bill passed in a historic vote last week by the U.S. House of Representatives would generate about $13.7 billion in net revenue for the U.S. treasury over the next decade, according to a new report by the Congressional Budget Office (CBO).

The National Basketball Association will not test its players for cannabis during the upcoming season, according to an NBC Sports report.

Aphria Inc. Announces Move to Nasdaq 2020-05-26 Melissa Schiller Aphria Inc., a global cannabis company, has announced that it will transfer its stock exchange listing from the New York Stock Exchange (NYSE) to The Nasdaq Global Select Market (Nasdaq).